Atovaquone/proguanil use and zoster vaccination are associated with reduced Alzheimer’s disease risk in two cohorts: implications for a latent Toxoplasma gondii mechanism

Related articles

1. Investigation of NLRP3, GSDMD, IL-1β and IL-18 expression in pediatric Crohn's disease with perianal lesions

   This article has 2 authors:

   1. Hongding Wang
   2. Zhongqin Jin

2. FDA-Approved Passive Immunization Treatments Against Aβ in Alzheimer’s Disease: Where Are We Now?

   This article has 3 authors:

   1. Martin Higgins
   2. Veronica Wasef
   3. Andrea Kwakowsky

3. PCSK9 Inhibitors Do Not Increase Cognitive Risk

   This article has 7 authors:

   1. Dongsheng Ni
   2. Zeying Feng
   3. Dehuan Liang
   4. Zhaolai Qi
   5. Yao Lu
   6. Liyong Zhu
   7. Guoping Li